Skip to main content

Table 1 Clinical characteristics, operative data, postoperative outcomes, and histopathologic features

From: Inferior mesenteric vein serves as an alternative guide for transection of the pancreatic body during pancreaticoduodenectomy with concomitant vascular resection: a comparative study evaluating perioperative outcomes

Variable

Modified procedures

Standard procedures (n = 75)

P b

P c

P d

Total (n = 62)

WATIMV (n = 28)

c-PD (n = 34)

Age (yr) (mean (SD))

57.8 ± 10.9

57.2 ± 10.9

58.1 ± 11.1

56.3 ± 10.8

0.398

0.63

0.87

Sex (Male/Female)

38/24

19/9

19/15

51/24

0.41

0.48

0.99

ASA score, n

    

0.75

0.89

0.96

1

28

13

15

35

   

2

24

10

14

25

   

3

10

5

5

15

   

Operative data

       

Length of vein resection, mm (95% CI)

24.19 (22.93 to 25.46)

24.64 (22.67 to 26.61)

23.82(22.1 to 25.54)

20.91 (19.39 to 22.42)

0.002

0.59

0.005

Blood loss, mL (95% CI)

679.8 (557.1 to 802.5)

533.9 (426.7 to 641.2)

800(597.8 to 1002.2)

509.3 (442.7 to 575.9)

0.018

0.013

0.79

Blood loss 500 mL, n

36

13

23

27

0.01

0.012

0.99

Blood transfusion, n

31

10

20

21

0.008

0.07

0.45

Histopathology

       

Tumor differentiation, n

    

0.41

0.97

0.66

Well

0

0

0

2

   

Moderate

22

10

12

28

   

Poor

40

18

22

45

   

Overall stage a, n

    

0.14

0.58

0.52

1B

0

0

0

3

   

2A

34

16

17

47

   

2B

29

12

17

24

   

3

0

0

0

0

   

4

0

0

0

1

   

Neural invasion, n

39

18

21

24

0.001

0.84

0.003

Vascular invasion, n

46

21

25

27

0.001

0.895

0.001

Depth of venous wall invasion, No

    

0.001

0.56

0.001

Adventitia

9

3

6

11

   

Tunica media

24

10

14

10

   

Intima

13

8

5

6

   

Lymph node metastasis, n

29

12

17

25

0.11

0.58

0.37

R1 Margin, n

9

1

8

5

0.13

0.06

0.9

Site of positive margin (no. (%))

       

Pancreas

3

0

3

1

   

Retroperitoneum

6

1

5

4

   

Postoperative data

       

Medical complications, n

30

13

17

35

0.84

0.78

0.98

Grade of complications

    

0.09

0.83

0.057

0

32

15

17

40

   

1

9

4

5

13

   

2

13

5

8

16

   

3

7

4

3

1

   

4

0

0

0

4

   

5 Mortality, n

1

0

1

1

   

Postoperative hospital stay (days) (mean (SD))

17 ± 9.7

15 ± 7.1

18.6 ± 11.3

14.2 ± 5.8

0.55

0.095

0.67

  1. aAmerican Joint Committee on Cancer (AJCC) Cancer Staging Manual, 7th edition.
  2. PbPatients who underwent standard PD with vein resection procedure (s-PD + VR, n = 75) versus modified procedure (m-PD + VR, n = 62).
  3. PcFurther stratification of the entire cohort of m-PD + VR group, ‘Whipple at IMV’ procedure (WATIMV n = 28) versus transection procedure as in the ‘central pancreatectomy’ (c-PD + VR, n = 34); P dPatients who underwent standard PD with vein resection procedure (s-PD + VR, n = 75) versus ‘Whipple at IMV’ procedure (WATIMV, n = 28). ASA, American Society of Anesthesiologists; WATIMV, Whipple at inferior mesenteric vein.